Effect of ON-tDCS on Memory Function Improvement and Related Circuits in Stable Depression Patients
Effect of Transcranial Direct Current Stimulation of the Greater Occipital Nerve on Memory Function Improvement and and the Locus Coeruleus-Noradrenergic Circuits in Stable Depression Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
So far, antidepressant drugs have limited memory improvement. Transcranial direct current stimulation, as a non-invasive and safe neuroregulatory technique, is a new direction to improve memory.In this study, transcranial direct current stimulation of the greater occipital nerve was used to explore the effect of improving memory function in patients with stable depression, and related studies were conducted on the locus coeruleus-noadrenal loop and the functional connection between locus coeruleus, hippocampus and amygdala.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 22, 2022
CompletedFirst Posted
Study publicly available on registry
December 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedDecember 2, 2022
November 1, 2022
1.2 years
November 22, 2022
November 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in working memory test scores after intervention.
The working memory test consists of two parts, which measure the breadth and accuracy of working memory respectively. The breadth of working memory will be tested using the operating span experiment, as the accuracy of working memory will be tested using the Memory Orientation experiment.
Baseline, 2-week, 2-month
Secondary Outcomes (2)
Change in three component test of executive function scores after intervention.
Baseline, 2-week, 2-month
Change in the test of logical memory on the Wechsler Memory Test score after intervention.
Baseline, 2-week, 2-month
Study Arms (2)
Active ON-tDCS
ACTIVE COMPARATORThe active group will receive the active transcranial direct current stimulation via a saline-soaked pair of surface sponges. Patients received this treatment protocol for 5 consecutive days.
Sham ON-tDCS
SHAM COMPARATORThe sham group will also receive the transcranial direct current stimulation for 5 consecutive days on sham procedure. The rationale behind this sham procedure was to mimic the transient skin sensation at the beginning of active ON-tDCS without producing any conditioning effects on the brain.
Interventions
DC was transmitted via a saline-soaked pair of surface sponges and delivered by specially developed, battery-driven, constant current stimulator with a maximum output of 2 mA. For each participant receiving ON-tDCS, the anodal electrode placed over the left C2 nerve dermatome, and cathodal electrode placed over the right C2 dermatome. A constant current of 1.5 mA was applied for 20 min.
For sham group, placement of the electrodes was identical to that of active ON-tDCS. ON-tDCS was first switched on in a ramp-up fashion over 5 s. Current intensity (ramp down) was gradually reduced (over 5 s) as soon as ON-tDCS reached a current flow of 1.5 mA. Hence, sham ON-tDCS only lasted 10 s (as opposed to 20 min in the active group).
Eligibility Criteria
You may qualify if:
- Eligible for ICD-10 depressive episode (F32) or recurrent depressive disorder (F33) diagnosis;
- Antidepressant therapy for at least 8 weeks, with no antidepressant adjustment for nearly 2 months
- HAMD-17 scores ≤ 7 points at the time of enrollment; CGI score ≦2;
- Chief complaint of memory impairment, PDQ-D score of cognitive impairment ≧17 points;
- Right-handed.
You may not qualify if:
- A history of major physical diseases;
- Have other mental disorders that meet the diagnostic criteria of ICD-10;
- Hearing, color blindness, color weakness or receive electroconvulsive therapy;
- Alcohol dependence or substance abuse;
- Patients with intellectual disability;
- Pregnant or lactating women or those planning to become pregnant;
- Patients with contraindications to tDCS.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Zhejiang University
Hanzhou, Zhejiang, 310009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2022
First Posted
December 2, 2022
Study Start
October 1, 2022
Primary Completion
December 31, 2023
Study Completion
October 1, 2024
Last Updated
December 2, 2022
Record last verified: 2022-11